Keywords: Treatment Response, Cancer
Motivation: Research on how primary breast tumours in situ respond to radiotherapy is very limited, though increasingly relevant as neo-adjuvant radiotherapy trials expand, requiring accurate and sensitive monitoring of therapy response.
Goal(s): To evaluate MRI response in breast tumours treated with radiotherapy and assess whether ADC values or their changes predict long-term outcomes.
Approach: Twenty-five patients underwent radiotherapy to in-situ breast tumours with the aim of long-term control. CE-DW-MRI was performed at baseline and 2W, 6M and 12M post-radiotherapy.
Results: Early ADC changes at 2-weeks post-radiotherapy correlated more strongly with long-term response than later ADC changes.
Impact: Early assessment of ADC on DW-MRI after radiotherapy treatment could predict long term responses in breast tumours. This could allow future personalisation of radiotherapy doses based on baseline ADC values of tumours.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords